Check out these 10 practical steps and oncologist insights to put most of your fears about dying from breast cancer to rest.

Get the facts about the most common gynecological cancer, including risk factors, diagnosis, treatments, and more, straight from a doctor.

Emily Dumler had 6 months to live after unsuccessful treatment for non-Hodgkin’s lymphoma, but has been in remission for three years since receiving CAR T-cell therapy.

Follicular lymphoma is a slow-growing cancer which is not curable but instead is considered a long-term, chronic disease.

If you or someone you love has been diagnosed with this type of uterine cancer, knowing their MSI status could impact treatment.

Diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma, is aggressive, but up to three-quarters of patients are responsive to treatment.

Microsatellite instability (MSI) doesn’t have anything to do with satellites in the sky, but it can have serious implications for endometrial cancer risk and future treatments. Here’s what you should know.

Could your endometrial cancer be caused by microsatellite instability, the cause of at least 20 percent of endometrial cancers? Here’s how to find out.

Gynecologic oncologist Mian Shahzad, M.D., answers our top questions on how MSI impacts endometrial cancer.

Non-Hodgkin’s lymphoma symptoms like fatigue, chills, and swollen glands are easy to mistake for minor ailments, but get a checkup if they persist.